Stephanie L. Van Bebber

688 total citations
17 papers, 491 citations indexed

About

Stephanie L. Van Bebber is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Oncology. According to data from OpenAlex, Stephanie L. Van Bebber has authored 17 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 7 papers in Economics and Econometrics and 5 papers in Oncology. Recurrent topics in Stephanie L. Van Bebber's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Health and Medical Research Impacts (3 papers). Stephanie L. Van Bebber is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Health and Medical Research Impacts (3 papers). Stephanie L. Van Bebber collaborates with scholars based in United States and Canada. Stephanie L. Van Bebber's co-authors include Kathryn A. Phillips, Julia R. Trosman, Kathryn A. Phillips, Su‐Ying Liang, Jennifer S. Haas, Karla Kerlikowske, David A. Lieberman, Uri Ladabaum, Robert A. Hiatt and Robin Kate Kelley and has published in prestigious journals such as Nature Reviews Drug Discovery, Medical Care and Contraception.

In The Last Decade

Stephanie L. Van Bebber

17 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephanie L. Van Bebber United States 11 173 132 98 77 75 17 491
Karen Tricker United Kingdom 6 132 0.8× 69 0.5× 98 1.0× 35 0.5× 98 1.3× 6 452
R. Ryanne Wu United States 14 144 0.8× 73 0.6× 51 0.5× 74 1.0× 228 3.0× 33 532
Kui Huang United States 13 97 0.6× 50 0.4× 30 0.3× 98 1.3× 77 1.0× 29 613
R. Vree Netherlands 8 181 1.0× 61 0.5× 60 0.6× 44 0.6× 62 0.8× 12 371
Cathelijne H. van der Wouden Netherlands 8 130 0.8× 54 0.4× 251 2.6× 22 0.3× 142 1.9× 10 493
Kristen McCullough United States 16 146 0.8× 28 0.2× 204 2.1× 76 1.0× 98 1.3× 53 805
Jennifer Westrup United States 7 268 1.5× 48 0.4× 18 0.2× 34 0.4× 129 1.7× 12 562
Peter J. Hulick United States 16 87 0.5× 66 0.5× 227 2.3× 54 0.7× 375 5.0× 46 852
Adriano V. Laudico Philippines 13 397 2.3× 43 0.3× 18 0.2× 32 0.4× 75 1.0× 27 559
Deborah Casso United States 10 240 1.4× 56 0.4× 12 0.1× 30 0.4× 45 0.6× 16 468

Countries citing papers authored by Stephanie L. Van Bebber

Since Specialization
Citations

This map shows the geographic impact of Stephanie L. Van Bebber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie L. Van Bebber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie L. Van Bebber more than expected).

Fields of papers citing papers by Stephanie L. Van Bebber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie L. Van Bebber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie L. Van Bebber. The network helps show where Stephanie L. Van Bebber may publish in the future.

Co-authorship network of co-authors of Stephanie L. Van Bebber

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie L. Van Bebber. A scholar is included among the top collaborators of Stephanie L. Van Bebber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie L. Van Bebber. Stephanie L. Van Bebber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hixson, John, et al.. (2015). Interest in a Digital Health Tool in Veterans With Epilepsy: Results of a Phone Survey. Military Medicine. 180(4). 387–390. 4 indexed citations
2.
Kelley, Robin Kate, Stephanie L. Van Bebber, Kathryn A. Phillips, & Alan P. Venook. (2011). Personalized Medicine and Oncology Practice Guidelines: A Case Study of Contemporary Biomarkers in Colorectal Cancer. Journal of the National Comprehensive Cancer Network. 9(1). 13–25. 32 indexed citations
3.
Trosman, Julia R., Stephanie L. Van Bebber, & Kathryn A. Phillips. (2011). Health Technology Assessment and Private Payers' Coverage of Personalized Medicine. Journal of Oncology Practice. 7(3S). 18s–24s. 47 indexed citations
4.
Bebber, Stephanie L. Van, Julia R. Trosman, Su‐Ying Liang, et al.. (2010). Capacity Building for Assessing New Technologies: Approaches to Examining Personalized Medicine In Practice. Personalized Medicine. 7(4). 427–439. 8 indexed citations
5.
Trosman, Julia R., Stephanie L. Van Bebber, & Kathryn A. Phillips. (2010). Coverage Policy Development for Personalized Medicine: Private Payer Perspectives on Developing Policy for the 21-Gene Assay. Journal of Oncology Practice. 6(5). 238–242. 45 indexed citations
6.
Phillips, Kathryn A., Su‐Ying Liang, Uri Ladabaum, et al.. (2007). Trends in Colonoscopy for Colorectal Cancer Screening. Medical Care. 45(2). 160–167. 115 indexed citations
7.
Bebber, Stephanie L. Van, Su‐Ying Liang, Kathryn A. Phillips, et al.. (2007). Valuing Personalized Medicine: Willingness to Pay for Genetic Testing for Colorectal Cancer Risk. Personalized Medicine. 4(3). 341–350. 11 indexed citations
8.
Kearney, Thomas E., et al.. (2006). Protocols for Pediatric Poisonings from Nontoxic Substances. Pediatric Emergency Care. 22(4). 215–221. 1 indexed citations
9.
Bebber, Stephanie L. Van, Kathryn A. Phillips, Tracy A. Weitz, Heather Gould, & Felicia Stewart. (2006). Patient costs for medication abortion: Results from a study of five clinical practices. Women s Health Issues. 16(1). 4–13. 15 indexed citations
10.
Phillips, Kathryn A., Stephanie L. Van Bebber, & Amalia M. Issa. (2006). Initial Development of an Evidence Base for Personalized Medicine‘s Translation to Clinical Practice and Health Policy. Personalized Medicine. 3(4). 411–414. 5 indexed citations
11.
Issa, Amalia M., et al.. (2006). Innovation in Personalized Medicine: Bidil ® as a Case Study for Integrating Clinical and Policy Developments. Personalized Medicine. 3(4). 421–427. 1 indexed citations
12.
Bebber, Stephanie L. Van, Hugh L. Keegan, Kathryn A. Phillips, & Amalia M. Issa. (2006). Novel Personalized Medicine Technology: UGT1A1 Testing for Irinotecan as a Case Study. Personalized Medicine. 3(4). 415–419. 8 indexed citations
13.
Afable‐Munsuz, Aimee, et al.. (2006). Provider practice models for and costs of delivering medication abortion — evidence from 11 US abortion care settings. Contraception. 75(1). 45–51. 11 indexed citations
14.
Phillips, Kathryn A. & Stephanie L. Van Bebber. (2006). Regulatory Perspectives on Pharmacogenomics: A Review of the Literature on Key Issues Faced by the United States Food and Drug Administration. Medical Care Research and Review. 63(3). 301–326. 17 indexed citations
15.
Phillips, Kathryn A. & Stephanie L. Van Bebber. (2005). Measuring the value of pharmacogenomics. Nature Reviews Drug Discovery. 4(6). 500–509. 67 indexed citations
16.
Phillips, Kathryn A., David L. Veenstra, Scott D. Ramsey, Stephanie L. Van Bebber, & Julie Sakowski. (2004). Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs.. PubMed. 10(7 Pt 1). 425–32. 37 indexed citations
17.
Phillips, Kathryn A. & Stephanie L. Van Bebber. (2004). A systematic review of cost-effectiveness analyses of pharmacogenomic interventions. Pharmacogenomics. 5(8). 1139–1149. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen Tricker Breakdown of academic impact, for papers by R. Ryanne Wu Breakdown of academic impact, for papers by Kui Huang Breakdown of academic impact, for papers by R. Vree Breakdown of academic impact, for papers by Cathelijne H. van der Wouden Breakdown of academic impact, for papers by Kristen McCullough Breakdown of academic impact, for papers by Jennifer Westrup Breakdown of academic impact, for papers by Peter J. Hulick Breakdown of academic impact, for papers by Adriano V. Laudico Breakdown of academic impact, for papers by Deborah Casso
Rankless by CCL
2026